Table 1.
Epidemiologic characteristics of the study population.
| SCLE | DLE | Control | |
|---|---|---|---|
| Age (SD) | 55.18 (14.86) | 49.96 (14.97) | 50.34 (10.47) |
| Sex | |||
| Female, n (%) | 33 (50.00%) | 14 (21.21%) | 30 (49.18%) |
| Male, n (%) | 5 (7.58%) | 14 (21.21%) | 31 (50.82%) |
| Biopsy Location: | |||
| Scalp, n (%) | 0 (0) | 3 (10.71%) | 3 (4.92%) |
| Forehead, n (%) | 0 (0) | 5 (17.86%) | 5 (8.20%) |
| Nose, n (%) | 0 (0) | 3 (10.71%) | 3 (4.92%) |
| Cheek, n (%) | 0 (0) | 9 (32.14%) | 9 (14.75%) |
| Neck, n (%) | 3 (7.89%) | 3 (10.71%) | 5 (8.20%) |
| Chest, n (%) | 14 (36.84%) | 0 (0) | 13 (21.31%) |
| Back, n (%) | 10 (26.32%) | 0 (0) | 9 (14.75%) |
| Arm, n (%) | 7 (18.42%) | 4 (14.28%) | 9 (14.75%) |
| Hand, n (%) | 2 (5.26%) | 1 (3.57%) | 3 (4.92%) |
| Abdomen, n (%) | 2 (5.26%) | 0 (0) | 2 (3.28%) |
| Buttock, n (%) | 0 (0) | 0 (0) | 0 (0) |
SCLE—subacute cutaneous lupus erythematosus, DLE—discoid lupus erythematosus; LE—the patients with SCLE or DLE treated with HCQ; HCQ—hydroxychloroquine.